Amphivena Therapeutics Receives $14,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6aa3a6c-e17b-43eb-b62c-ab7354bb5172
Date
5/4/2015
Company Name
Amphivena Therapeutics
Mailing Address
45 Juniper Street San Francisco, CA 94103 USA
Company Description
Amphivena Therapeutics Inc., a newly created subsidiary of venture-backed Affimed Therapeutics AG , has raised $14 million in Series A financing and has granted Janssen Biotech an exclusive option to acquire the company.
Website
http://www.amphivena.com
Transaction Type
Venture Equity
Transaction Amount
$14,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Venture Investor